Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

TCRαβ/CD19 cell–depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis

Blood (2024) 143 (3): 279–289.

https://doi.org/10.1182/blood.2023021336

Published: 2024

Includes: Supplemental data

Journal Articles

Interindividual HLA Evolutionary Divergence in Single HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation for Malignant Hematological Disorders: A Report on Behalf of the Cellular Therapy and Immunobiology Working Party of the EBMT

Blood (2023) 142 (Supplement 1): 895.

https://doi.org/10.1182/blood-2023-187622

Published: 2023

Journal Articles

Outcomes of Unrelated Bone Marrow Transplantation in Patients with Thalassemia

Javid Gaziev, Antonella Isgro, MD, Katia Paciaroni, MD, Marco Marziali, MD, Gioia De Angelis, MD, Michela Ribersani, MD, Cecilia Alfieri, MD, Marco Andreani, PhD

Blood (2018) 132 (Supplement 1): 5777.

https://doi.org/10.1182/blood-2018-99-109764

Published: 2018

Journal Articles

High Resolution Donor/Recipient HLA Matching Level in Unrelated Hematopoietic Stem Cell Transplantation and Impact on the Transplant Outcome: The Italian Experience on Behalf of GITMO, IBMDR and Aibt

Blood (2018) 132 (Supplement 1): 4642.

https://doi.org/10.1182/blood-2018-99-114486

Published: 2018

Journal Articles

Long-Term Outcome after Haploidentical Hematopoietic Cell Transplantation Utilizing CD34+ Selected/CD3CD19+ Depleted or Tcrαβ+/CD19+ Depleted Grafts in Pediatric Patients with Hemoglobinopathies

Javid Gaziev, Antonella Isgrò, MD, Pietro Sodani, MD, Katia Paciaroni, MD, Gioia De Angelis, MD, Marco Marziali, MD, Michela Ribersani, MD, Cecilia Alfieri, MD, Marco Andreani, PhD, Tiziana Gallucci, PhD, Guido Lucarelli, MD

Blood (2017) 130 (Supplement 1): 663.

https://doi.org/10.1182/blood.V130.Suppl_1.663.663

Published: 2017

Journal Articles

Evaluation of the Impact of Anti-Thymocyte Globulin on Post-Transplant Outcomes in Sickle Cell Anemia Patients Undergoing BMT from HLA-Identical Sibling Donors

Javid Gaziev, MD, Antonella Isgro, MD, Marco Marziali, MD, Katia Paciaroni, MD, Gioia De Angelis, MD, Marco Andreani, PhD, Cecilia Alfieri, MD, Michela Ribersani, MD, Guido Lucarelli, MD

Blood (2016) 128 (22): 3468.

https://doi.org/10.1182/blood.V128.22.3468.3468

Published: 2016

Journal Articles

Optimal Outcomes after Second Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Recurrence Following Graft Failure/Rejection of the First Graft

Javid Gaziev, MD, Katia Paciaroni, MD, Gioia De Angelis, MD, Antonella Isgro, MD, Marco Marziali, MD, Marco Andreani, PhD, Cecilia Alfieri, MD, Michela Ribersani, MD, Guido Lucarelli, MD

Blood (2016) 128 (22): 2289.

https://doi.org/10.1182/blood.V128.22.2289.2289

Published: 2016

Journal Articles

Children with Acute Leukemia Given Hematopoietic Stem Cell Transplantation (HSCT) from an HLA-Compatible Sibling, or an Unrelated Donor (UD) or an HLA-Haploidentical Relative after Alpha/Beta T-Cell Depletion Have a Comparable Outcome

Alice Bertaina, MDPhD, Barbarella Lucarelli, MD, Riccardo Masetti, MD, Pietro Merli, MD, Roberto Rondelli, MD, Giuseppina Li Pira, PhD, Marco Andreani, PhD, Lavinia Grapulin, MD, Daniela Pende, MD, Michela Falco, PhD, Maria Rita Pinto, MD, Valentina Bertaina, PhD, Maria Teresa Romano, MD, Stefano Ceccarelli, MD, Letizia Pomponia Brescia, MD, Daria Pagliara, MD, Alessandro Moretta, MD, Lorenzo Moretta, MD, Franco Locatelli, Prof, MD PhD

Blood (2015) 126 (23): 195.

https://doi.org/10.1182/blood.V126.23.195.195

Published: 2015

Journal Articles

Hematopoietic Stem Cell Transplantation in Nigerian Children with Sickle Cell Anemia

Antonella Isgro, MD, Javid Gaziev, Pietro Sodani, MD, Marco Andreani, PhD, Manuela Testi, PhD, Katia Paciaroni, MD, Cristiano Gallucci, MD, Gioia De Angelis, MD, Marco Marziali, MD, Cecilia Alfieri, MD, Michela Ribersani, MD, Olufemi O Akinyanju, T. Thompson Wakama, Festus Olusola Olowoselu, Guido Lucarelli, MD

Blood (2015) 126 (23): 4598.

https://doi.org/10.1182/blood.V126.23.4598.4598

Published: 2015

Journal Articles

Transplant Outcomes in High-Risk (Class 3) Patients with Thalassemia Treated with a Modified Protocol Are Equivalent to Low/Intermediate-Risk (Class 1/Class 2) Patients

Javid Gaziev, MD, Gioia De Angelis, MD, Antonella Isgro, MD, Pietro Sodani, MD, Marco Marziali, MD, Katia Paciaroni, MD, Marco Andreani, PhD, Manuela Testi, PhD, Cristiano Gallucci, MD, Cecilia Alfieri, MD, Michela Ribersani, MD, Maria Troiano, PhD, Aldo Morrone, MD, Guido Lucarelli, MD

Blood (2015) 126 (23): 620.

https://doi.org/10.1182/blood.V126.23.620.620

Published: 2015

Journal Articles

Evolving Criteria of Donor Selection for Allogeneic Transplant in Acute Myeloid Leukemia

Blood (2015) 126 (23): 2004.

https://doi.org/10.1182/blood.V126.23.2004.2004

Published: 2015

Journal Articles

Bone Marrow Transplantation For Thalassemia Using Related Other Than HLA- Identical Siblings: Improved Transplant Outcomes With a Novel Approach

Javid Gaziev, Marco Marziali, Antonella Isgro, Pietro Sodani, Katia Paciaroni, Cristiano Gallucci, Gioia De Angelis, Cecilia Alfieri, Marco Andreani, BSc, Manuela Testi, Michela Ribersani, Luisa Cardarelli, Daniele Armiento, Guido Lucarelli

Blood (2013) 122 (21): 2040.

https://doi.org/10.1182/blood.V122.21.2040.2040

Published: 2013

Journal Articles

Removal Of Alpha/Beta+ T Cells and Of CD19+ B Cells From The Graft Translates Into Rapid Engraftment, Absence Of Visceral Graft-Versus-Host Disease and Low Transplant-Related Mortality In Children With Acute Leukemia Given HLA-Haploidentical Hematopoietic Stem Cell Transplantation

Blood (2013) 122 (21): 157.

https://doi.org/10.1182/blood.V122.21.157.157

Published: 2013

Journal Articles

Bone marrow transplantation for thalassemia from alternative related donors: improved outcomes with a new approach

Javid Gaziev, Marco Marziali, Antonella Isgrò, Pietro Sodani, Katia Paciaroni, Cristiano Gallucci, Marco Andreani, Manuela Testi, Gioia De Angelis, Cecilia Alfieri, Luisa Cardarelli, Michela Ribersani, Daniele Armiento, Guido Lucarelli

Blood (2013) 122 (15): 2751–2756.

https://doi.org/10.1182/blood-2013-07-513473

Published: 2013

Journal Articles

Haploidentical, unmanipulated, G-CSF–primed bone marrow transplantation for patients with high-risk hematologic malignancies

Paolo Di Bartolomeo, Stella Santarone, Gottardo De Angelis, Alessandra Picardi, Laura Cudillo, Raffaella Cerretti, Gaspare Adorno, Stefano Angelini, Marco Andreani, Lidia De Felice, Maria Cristina Rapanotti, Loredana Sarmati, Pasqua Bavaro, Gabriele Papalinetti, Marta Di Nicola, Franco Papola, Mauro Montanari, Arnon Nagler, William Arcese

Blood (2013) 121 (5): 849–857.

https://doi.org/10.1182/blood-2012-08-453399

Published: 2013

Journal Articles

A Novel Treatment Protocol Successfully Prevented Graft Rejection and Improved Disease-Free Survival in Class 3 Children with Thalassemia

Javid Gaziev, Pietro Sodani, Antonella Isgrò, Marco Marziali, Maria Domenico Simone, Fabio Torelli, Marco Andreani, Manuela Testi, Katia Paciaroni, Cristiano Gallucci, Andrea Roveda, Gioia De Angelis, Cecilia Alfieri, Guido Lucarelli

Blood (2011) 118 (21): 150.

https://doi.org/10.1182/blood.V118.21.150.150

Published: 2011

Journal Articles

Novel pharmacokinetic behavior of intravenous busulfan in children with thalassemia undergoing hematopoietic stem cell transplantation: a prospective evaluation of pharmacokinetic and pharmacodynamic profile with therapeutic drug monitoring

Javid Gaziev, Laurent Nguyen, Christian Puozzo, Alessia Francesca Mozzi, Marialuisa Casella, Michela Perrone Donnorso, Paolo Gravina, Pietro Sodani, Marco Marziali, Antonella Isgrò, Maria Domenica Simone, Marco Andreani, Amanda Formosa, Manuela Testi, Giorgio Federici, Sergio Bernardini, Guido Lucarelli

Blood (2010) 115 (22): 4597–4604.

https://doi.org/10.1182/blood-2010-01-265405

Published: 2010

Journal Articles

Purified T-depleted, CD34 + peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia

Blood (2010) 115 (6): 1296–1302.

https://doi.org/10.1182/blood-2009-05-218982

Published: 2010

Journal Articles

Bone Marrow Iron Concentration as a Marker of Iron Accumulation and Marrow Expansion in Patients with Beta Thalassemia Major.

Paola Polchi, Rossella Palmieri, Marco Andreani, Javid Gaziev, MD, Cecilia Alfieri, Gioia De Angelis, Cristiano Gallucci, Antonella Isgro, Marco Marziali, Katia Paciaroni, Andrea Roveda, Pietro Sodani, Guido Lucarelli

Blood (2008) 112 (11): 1852.

https://doi.org/10.1182/blood.V112.11.1852.1852

Published: 2008

Journal Articles

Early T Cell Recovery of Thymus-Derived Naive T Cells and NK Cells in Pediatrics Patients after T-Cell Depleted HLA-Haploidentical Stem Cell Transplantation for Thalassemia.

Antonella Isgro’, MD, PhD, Pietro Sodani, MD, Marco Marziali, MD, PhD, Buket Erer, MD, Cecilia Alfieri, MD, Javid Gaziev, MD, Marco Andreani, PhD, Wilma Leti, MD, Massimo Campagna, Fernando Aiuti, MD, Guido Lucarelli, MD

Blood (2007) 110 (11): 3816.

https://doi.org/10.1182/blood.V110.11.3816.3816

Published: 2007

NARROW

TCRαβ/CD19 cell–depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis

Interindividual HLA Evolutionary Divergence in Single HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation for Malignant Hematological Disorders: A Report on Behalf of the Cellular Therapy and Immunobiology Working Party of the EBMT

Outcomes of Unrelated Bone Marrow Transplantation in Patients with Thalassemia

High Resolution Donor/Recipient HLA Matching Level in Unrelated Hematopoietic Stem Cell Transplantation and Impact on the Transplant Outcome: The Italian Experience on Behalf of GITMO, IBMDR and Aibt

Long-Term Outcome after Haploidentical Hematopoietic Cell Transplantation Utilizing CD34+ Selected/CD3CD19+ Depleted or Tcrαβ+/CD19+ Depleted Grafts in Pediatric Patients with Hemoglobinopathies

Evaluation of the Impact of Anti-Thymocyte Globulin on Post-Transplant Outcomes in Sickle Cell Anemia Patients Undergoing BMT from HLA-Identical Sibling Donors

Optimal Outcomes after Second Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Recurrence Following Graft Failure/Rejection of the First Graft

Children with Acute Leukemia Given Hematopoietic Stem Cell Transplantation (HSCT) from an HLA-Compatible Sibling, or an Unrelated Donor (UD) or an HLA-Haploidentical Relative after Alpha/Beta T-Cell Depletion Have a Comparable Outcome

Hematopoietic Stem Cell Transplantation in Nigerian Children with Sickle Cell Anemia

Transplant Outcomes in High-Risk (Class 3) Patients with Thalassemia Treated with a Modified Protocol Are Equivalent to Low/Intermediate-Risk (Class 1/Class 2) Patients

Evolving Criteria of Donor Selection for Allogeneic Transplant in Acute Myeloid Leukemia

Bone Marrow Transplantation For Thalassemia Using Related Other Than HLA- Identical Siblings: Improved Transplant Outcomes With a Novel Approach

Removal Of Alpha/Beta+ T Cells and Of CD19+ B Cells From The Graft Translates Into Rapid Engraftment, Absence Of Visceral Graft-Versus-Host Disease and Low Transplant-Related Mortality In Children With Acute Leukemia Given HLA-Haploidentical Hematopoietic Stem Cell Transplantation

Bone marrow transplantation for thalassemia from alternative related donors: improved outcomes with a new approach

Haploidentical, unmanipulated, G-CSF–primed bone marrow transplantation for patients with high-risk hematologic malignancies

A Novel Treatment Protocol Successfully Prevented Graft Rejection and Improved Disease-Free Survival in Class 3 Children with Thalassemia

Novel pharmacokinetic behavior of intravenous busulfan in children with thalassemia undergoing hematopoietic stem cell transplantation: a prospective evaluation of pharmacokinetic and pharmacodynamic profile with therapeutic drug monitoring

Purified T-depleted, CD34 + peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia

Bone Marrow Iron Concentration as a Marker of Iron Accumulation and Marrow Expansion in Patients with Beta Thalassemia Major.

Early T Cell Recovery of Thymus-Derived Naive T Cells and NK Cells in Pediatrics Patients after T-Cell Depleted HLA-Haploidentical Stem Cell Transplantation for Thalassemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only